Ignite Creation Date:
2025-12-25 @ 2:27 AM
Ignite Modification Date:
2025-12-27 @ 10:59 PM
Study NCT ID:
NCT05585034
Status:
COMPLETED
Last Update Posted:
2025-08-07
First Post:
2022-10-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors
Sponsor:
Xencor, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-14
Start Date Type:
ACTUAL
Primary Completion Date:
2025-05-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-05-20
Completion Date Type:
ACTUAL
First Submit Date:
2022-10-11
First Submit QC Date:
None
Study First Post Date:
2022-10-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-05
Last Update Post Date:
2025-08-07
Last Update Post Date Type:
ACTUAL